Biorchestra Co.
Latest round
- Series C
Last raised
- Feb 2022
Total raised
- $64M
Investors
- 15
About Biorchestra Co.
, Ltd. operates as a biotech company that works on the research and development of ribonucleic acid (RNA) based therapeutics., Ltd. The company develops a treatment for RNA-based degenerative brain diseases such as Alzheimer’s and Lou Gehrig’s disease. The company also provides other services including drug delivery system, RNA therapeutics, diagnostics, and clinical approaches.
Who invested in Biorchestra Co.
15 investors across 3 rounds
See all investors in Biorchestra Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biorchestra Co.
Who invested in Biorchestra Co.?
Biorchestra Co. has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biorchestra Co. raised?
Biorchestra Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Biorchestra Co. last raise money?
Biorchestra Co.'s most recent round on record is a Series C, in Feb 2022.
What does Biorchestra Co. do?
Biorchestra Co. is a biotechnology company.
Where is Biorchestra Co. headquartered?
Biorchestra Co. is headquartered in Daejeon, South Korea.
Which VCs invest in companies like Biorchestra Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Biorchestra Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Biorchestra Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.